Blood protein clues may catch malnutrition early in cancer patients
NCT ID NCT03240835
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether three blood proteins (pre-albumin, retinol binding protein, and transferrin) can help detect early malnutrition in people with advanced nasopharyngeal cancer undergoing chemoradiotherapy. Researchers tracked 60 patients to see if these proteins change during treatment and relate to weight loss and side effects. The goal is to find a simple way to monitor nutrition and intervene sooner.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALNUTRITION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cancer Center, Sun Yat-sen University
Guangzhou, Guangdong, 510060, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could adding extra chemo before standard therapy beat nasopharyngeal cancer?
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?
- Can surgery for stomach or esophageal cancer cloud the mind?
- A simple drink may help seniors rebuild strength after illness
- Could a simple ultrasound and nutrition score forecast hip fracture recovery?
- Could a Nutrient-Rich diet tame the painful side effects of chemoradiotherapy?